Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-64 years old~* Untreated obstructive sleep apnea~Exclusion Criteria:~* Nadir SaO2 \<70% on a baseline PSG~* Medications known to affect either sleep, breathing or muscle activity~* Major co-morbidities apart from sleep apnea~* Allergy to lidocaine, oxymetazoline HCl, or eszopiclone~* Women who are pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Eszopiclone (Type: ACTIVE_COMPARATOR): Eszopiclone 3mg prior to sleep (1 night)
- Sugar Pill (Type: PLACEBO_COMPARATOR): Sugar Pill (placebo) prior to sleep (1 night)

Based on this trial design, predict the completion outcome and termination type (if applicable).